New CEO leads expansion of personalized medicine dosing assay company
A company specializing in diagnostic assays for personalized chemotherapy drug dosages has made its interim CEO permanent as it prepares for a national expansion. It is also developing an assay for early detection of Alzheimer’s disease. Kevin Harter, the co-founder of the Life Sciences Greenhouse, stepped in as interim CEO at Saladax Biomedical in Bethlehem, […]